Cold Genesys Obtains $13,570,000 Series A Funding

  • Feed Type
  • Date
    8/1/2014
  • Company Name
    Cold Genesys
  • Mailing Address
    1303 Avocado Avenue Newport Beach, CA 92660 USA
  • Company Description
    Cold Genesys, Inc. is seeking an integrated phase II/III clinical trial to study the effect of our lead product, CG0070, for patients with Non-Muscle Invasive Bladder Cancer (NMIBC).
  • Website
    http://www.coldgenesys.net
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $13,570,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor

By posting a comment, you agree to our terms and conditions.